| Oct 17 |
BIO Gears Up for Q3 Earnings: Here's What You Need to Know
|
| Oct 1 |
Should You Continue to Hold Bio-Rad Stock in Your Portfolio?
|
| Sep 9 |
Palantir Stock Jumps on S&P 500 Addition. Here’s Who Else Was Added.
|
| Sep 9 |
Palantir Soars, Dell Pops As Big AI Plays Finally Get S&P 500 Nod
|
| Sep 9 |
Palantir and Dell Will Join S&P 500—What You Need To Know
|
| Sep 6 |
Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
|
| Sep 6 |
National Vision (EYE) Down 6.9% Since Last Earnings Report: Can It Rebound?
|
| Aug 20 |
Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer
|
| Aug 6 |
Bio-Rad Laboratories, Inc. (BIO): Should You Invest In This Organ Transplant and Diagnosis Stock Right Now?
|
| Aug 2 |
Bio-Rad Laboratories, Inc. (BIO) Q2 2024 Earnings Call Transcript
|
